Journal of Surgical Research
Volume 166, Issue 2 , Pages 255-264 , April 2011

Upper Gastrointestinal Carcinogenesis: H. pylori and Stem Cell Cross-Talk

  • Ioannis Pilpilidis, M.D.

      Affiliations

    • Department of Gastroenterology, Second Medical Clinic, Aristotle University of Thessaloniki, Ippokration Hospital, Thessaloniki, Greece
    • ,
  • Jannis Kountouras, M.D., Ph.D.

      Affiliations

    • Department of Gastroenterology, Second Medical Clinic, Aristotle University of Thessaloniki, Ippokration Hospital, Thessaloniki, Greece
    • Corresponding Author InformationTo whom correspondence and reprint requests should be addressed at Department of Gastroenterology, Second Medical Clinic, Aristotle University of Thessaloniki, Ippokration Hospital, 8 Fanariou St., Byzantio, 551 33, Thessaloniki, Macedonia, Greece.
    • ,
  • Christos Zavos, M.D.

      Affiliations

    • Department of Gastroenterology, Second Medical Clinic, Aristotle University of Thessaloniki, Ippokration Hospital, Thessaloniki, Greece
    • ,
  • Panagiotis Katsinelos, M.D., Ph.D.

      Affiliations

    • Department of Endoscopy and Motility Unit, Central Hospital, Thessaloniki, Greece

Received 2 November 2009

References 

  1. MacFarlane AJ, Stover PJ. Convergence of genetic, nutritional and inflammatory factors in gastrointestinal cancers. Nutr Rev. 2007;65:s157
  2. Hynes M, Huang K, Huang E. Implications of the "cancer stem cell" hypothesis on murine models of colon cancer and colitis-associated cancer. Vet Pathol. 2009;46:819
  3. Jackson L, Evers BM. Chronic inflammation and pathogenesis of GI and pancreatic cancers. Cancer Treat Res. 2006;130:39
  4. Maeda S, Omata M. Inflammation and cancer: Role of nuclear factor-κB activation. Cancer Sci. 2008;99:836
  5. Li HC, Stoicov C, Rogers AB, et al. Stem cells and cancer: Evidence for bone marrow stem cells in epithelial cancers. World J Gastroenterol. 2006;12:363
  6. Quante M, Wang TC. Inflammation and stem cells in gastrointestinal carcinogenesis. Physiology. 2008;23:350
  7. Pilpilidis I, Gatopoulou A, Katsinelos P. Changing panorama of gastric cancer: Implications for upper GI endoscopy guidelines. In:  Cardinni Dorothy C editors. Research focus on gastric cancer. New York: Nova Science Publishers, Inc; 2008;p. 219
  8. Gumucio DL, Fagoonee S, Qiao XT, et al. Tissue stem cells and cancer stem cells: Potential implications for gastric cancer. Panminerva Med. 2008;50:65
  9. Kountouras J, Zavos C, Chatzopoulos D, et al. New aspects of Helicobacter pylori infection involvement in gastric oncogenesis. J Surg Res. 2008;146:149
  10. Lobo NA, Shimono Y, Qian D, et al. The biology of cancer stem cells. Annu Rev Cell Dev Biol. 2007;23:675
  11. Charafe-Jauffret E, Monville F, Ginestier C, et al. Cancer stem cells in breast: Current opinion and future challenges. Pathobiology. 2008;75:75
  12. Hanahan D, Weinberg R. The hallmarks of cancer. Cell. 2000;100:57
  13. Bonnet D, Dick JE. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med. 1997;3:730
  14. Leedham SJ, Schier S, Thliveris AT, et al. From gene mutations to tumours – Stem cells in gastrointestinal carcinogenesis. Cell Prolif. 2005;38:387
  15. Chambers AF, Naumov GN, Vantyghem SA, et al. Molecular biology of breast cancer metastasis. Clinical implications of experimental studies on metastatic inefficiency. Breast Cancer Res. 2000;2:400
  16. Lee JT, Herlyn M. Old disease, new culprit: Tumor stem cells in cancer. J Cell Physiol. 2007;213:603
  17. Styczynski J, Drewa T. Leukemic stem cells: From metabolic pathways and signaling to a new concept of drug resistance targeting. Acta Biochim Pol. 2007;54:717
  18. McDonald SA, Preston SL, Lovell MJ, et al. Mechanisms of disease: From stem cells to colorectal cancer. Nat Clin Pract Gastroenterol Hepatol. 2006;3:267
  19. Jackson L, Evers BM. Chronic inflammation and pathogenesis of GI and pancreatic cancers. Cancer Treat Res. 2006;130:39
  20. Rapp UR, Ceteci F, Schreck R. Oncogene-induced plasticity and cancer stem cells. Cell Cycle. 2008;7:45
  21. Karam SM. Cellular origin of gastric cancer. Ann N Y Acad Sci. 2008;1138:162
  22. Katoh M. Dysregulation of stem cell signaling network due to germline mutation, SNP, Helicobacter pylori infection, epigenetic change and genetic alteration in gastric cancer. Cancer Biol Ther. 2007;6:832
  23. Byun T, Karimi M, Marsh JL, et al. Expression of secreted Wnt antagonists in gastrointestinal tissues: Potential role in stem cell homeostasis. J Clin Pathol. 2005;58:515
  24. Alvarez-Medina R, Le Dreau G, Ros M, et al. Hedgehog activation is required upstream of Wnt signalling to control neural progenitor proliferation. Development. 2009;136:3301
  25. Klaus A, Birschmeier W. Wnt signalling and its impact on development and cancer. Nat Cancer Rev. 2008;8:387
  26. Ling L, Nurcombe V, Cool SM. Wnt signaling controls the fate of mesenchymal stem cells. Gene. 2009;433:1
  27. Saitoh T, Mine T, Katoh M. Expression and regulation of WNT8A and WNT8B mRNAs in human tumor cell lines: Up-regulation of WNT8B mRNA by β-estradiol in MCF-7 cells, and down-regulation of WNT8A and WNT8B mRNAs by retinoic acid in NT2 cells. Int J Oncol. 2002;20:999
  28. Katoh M. Frequent up-regulation of WNT2 in primary gastric cancer and colorectal cancer. Int J Oncol. 2001;19:1003
  29. Saitoh T, Kirikoshi H, Mine T, et al. Proto-oncogene WNT10B is upregulated by tumor necrosis factor alpha in human gastric cancer cell line MKN45. Int J Oncol. 2001;19:1187
  30. Kirikoshi H, Sekihara H, Katoh M. Up-regulation of WNT10A by tumor necrosis factor alpha and Helicobacter pylori in gastric cancer. Int J Oncol. 2001;19:533
  31. Katoh M, Katoh M. Notch signaling in the gastrointestinal tract. Int J Oncol. 2007;30:247
  32. Li DW, Wu Q, Peng ZH, et al. Expression and significance of Notch1 and PTEN in gastric cancer. Ai Zheng. 2007;26:1183
  33. Katoh Y, Katoh M. Hedgehog signaling pathway and gastrointestinal stem cell signaling network (review). Int J Mol Med. 2006;18:1019
  34. Grose R, Dickson C. Fibroblast growth factor signaling in tumorigenesis. Cytokine Growth Factor Rev. 2005;16:179
  35. McCubrey J, Steelman L, Chapell W, et al. Roles of the Raf/MEK/ERK pathway in cell growth, malignant transformation and drug resistance. Bioch Biophys Acta. 2007;1773:1263
  36. Cohen MM. Molecular dimensions of gastrointestinal tumors: Some thoughts for digestion. Am J Med Genet. 2003;122:303
  37. Katoh M. Cancer genomics and genetics of FGFR2. Int J Oncol. 2008;33:233
  38. Katoh M, Terada M. Overexpression of bone morphogenetic protein (BMP)-4 mRNA in gastric cancer cell lines of poorly differentiated type. J Gastroenterol. 1996;31:137
  39. Hatakeyama M, Higashi H. Helicobacter pylori CagA: A new paradigm for bacterial carcinogenesis. Cancer Sci. 2005;96:835
  40. Blitz I, Cho K. Finding partners: How BMPs select their targets. Develop Dynamic. 2009;238:1321
  41. Bleuming SA, Kodach LL, Garcia Leon MJ, et al. Altered bone morphogenetic protein signalling in the Helicobacter pylori-infected stomach. J Pathol. 2006;209:190
  42. Lees C, Howie S, Sartor RB, et al. The hedgehog signalling pathway in the gastrointestinal tract: Implications for development, homeostasis, and disease. Gastroenterology. 2005;129:1696
  43. Waschek JA, Dicicco-Bloom E, Nicot A, et al. Hedgehog signaling: New targets for GPCRs coupled to cAMP and protein kinase A. Ann N Y Acad Sci. 2006;1070:120
  44. Katoh Y, Katoh M. Hedgehog target genes: Mechanisms of carcinogenesis induced by aberrant hedgehog signaling activation. Curr Mol Med. 2009;9:873
  45. Nishizawa T, Suzuki H, Nakagawa I, et al. Rebamipide-promoted restoration of gastric mucosal sonic hedgehog expression after early Helicobacter pylori eradication. Digestion. 2009;79:259
  46. Stepan V, Ramamoorthy S, Nitsche H, et al. Regulation and function of the sonic hedgehog signal transduction pathway in isolated gastric parietal cells. J Biol Chem. 2005;280:15700
  47. Ma X, Sheng T, Zhang Y, et al. Hedgehog signaling is activatedin subsets of esophageal cancers. Int J Cancer. 2006;118:139
  48. Ma X, Chen K, Huang S, et al. Frequent activation of the hedgehog pathway in advanced gastric adenocarcinomas. Carcinogenesis. 2005;26:1698
  49. Berman DM, Karhadkar SS, Maitra A, et al. Widespread requirement for Hedgehog ligand stimulation in growth of digestive tract tumors. Nature. 2003;425:846
  50. Martin ST, Sato N, Dhara S, et al. Aberrant methylation of the human Hedgehog interacting protein (HHIP) gene in pancreatic neoplasms. Cancer Biol Ther. 2005;4:728
  51. Shiotani A, Iishi H, Uedo N, et al. Helicobacter pylori-induced atrophic gastritis progressing to gastric cancer exhibits sonic hedgehog loss and aberrant CDX2 expression. Aliment Pharmacol Ther. 2006;24:s71
  52. Shiotani A, Iishi H, Uedo N, et al. Evidence that loss of sonic hedgehog is an indicator of Helicobacter pylori-induced atrophic gastritis progressing to gastric cancer. Am J Gastroenterol. 2005;100:581
  53. Nishizawa T, Suzuki H, Masaoka T, et al. Helicobacter pylori eradication restored sonic hedgehog expression in the stomach. Hepatogastroenterology. 2007;54:697
  54. Nishizawa T, Suzuki H, Nakagawa I, et al. Early Helicobacter pylori eradication restores sonic hedgehog expression in the gastric mucosa of Mongolian gerbils. Digestion. 2009;79:99
  55. Hatakeyama M. Helicobacter pylori and gastric carcinogenesis. J Gastroenterol. 2009;44:239
  56. Li S. Src kinase signaling in leukaemia. Int J Biochem Cell Biol. 2007;39:1483
  57. Chen J, Yu WM, Daino H, et al. SHP-2 phosphatase is required for hematopoietic cell transformation by Bcr-Abl. Blood. 2007;109:778
  58. Schnidar H, Eberl M, Klingler S, et al. Epidermal growth factor receptor signaling synergizes with Hedgehog/GLI in oncogenic transformation via activation of the MEK/ERK/JUN pathway. Cancer Res. 2009;69:1284
  59. Giannakis M, Chen SL, Karam SM, et al. Helicobacter pylori evolution during progression from chronic atrophic gastritis to gastric cancer and its impact on gastric stem cells. Proc Natl Acad Sci USA. 2008;18(105):4358
  60. Bjerknes M, Cheng H. Multipotential stem cells in adult mouse gastric epithelium. Am J Physiol Gastrointest Liver Physiol. 2002;283:G767
  61. Kato K, Hasui K, Wang J, et al. Homeostatic mass control in gastric non-neoplastic epithelia under infection of Helicobacter pylori: An immunohistochemical analysis of cell growth, stem cells and programmed cell death. Acta Histochem Cytochem. 2008;41:23
  62. Fukuda K, Saikawa Y, Ohashi M, et al. Tumor initiating potential of side population cells in human gastric cancer. Int J Oncol. 2009;34:1201
  63. Takaishi S, Okumura T, Tu S, et al. Identification of gastric cancer stem cells using the cell surface marker CD44. Stem Cells. 2009;27:1006
  64. Fan X, Long A, Goggins M, et al. Expression of CD44 and its variants on gastric epithelial cells of patients with Helicobacter pylori colonisation. Gut. 1996;38:507
  65. Peng AB, Shi W, Hu SH, et al. Expression of CD44v6 in gastric cancer and its correlation with Helicobacter pylori infection. Ai Zheng. 2003;22:1184
  66. Houghton J, Wang TC. Helicobacter pylori and gastric cancer: A new paradigm for inflammation-associated epithelial cancers. Gastroenterology. 2005;128:1567
  67. Houghton J, Stoicov C, Normura S, et al. Gastric cancer originating from bone marrow-derived cells. Science. 2004;306:1568
  68. Kountouras J, Zavos C, Chatzopoulos D. Pathogenetic links between colorectal neoplasia and Barrett's esophagus. Gastrointest Endosc. 2006;64:298
  69. Direkze N, Hodivala-Dilke K, Jeffery R, et al. Bone marrow contribution to tumor-associated myofibroblasts and fibroblasts. Cancer Res. 2004;64:8492
  70. Kaplan RN, Riba RD, Zacharoulis S, et al. VEGFR1-positive haematopoietic bone marrow progenitors initiate the premetastatic niche. Nature. 2005;438:820
  71. Figueiredo C, Machado JC, Pharoah P, et al. Helicobacter pylori and interleukin 1 genotyping: An opportunity to identify high-risk individuals for gastric carcinoma. J Natl Cancer Inst. 2002;94:1680
  72. Sakuma K, Uozaki H, Chong JM. Cancer risk to the gastric corpus in Japanese, its correlation with Interleukin-1b gene polymorphism (+3953∗T) and Epstein-Barr virus infection. Int J Cancer. 2005;115:93
  73. El-Omar EM, Rabkin CS, Gammon MD, et al. Increased risk of noncardiac gastric cancer associated with proinflammatory cytokine gene polymorphisms. Gastroenterology. 2003;124:1193
  74. Takaishi S, Okumura T, Wang T. Gastric cancer stem cells. J Clin Oncol. 2008;26:2876
  75. Rodriguez Mdel C, Bernad A, et al. Interleukin-6 deficiency affects bone marrow stromal precursors, resulting in defective hematopoietic support. Blood. 2004;103:3349
  76. Wu CY, Wang CJ, Tseng CC, et al. Helicobacter pylori promote gastric cancer cells invasion through a NF-κB and COX-2-mediated pathway. World J Gastroenterol. 2005;11:3197
  77. Orimo A, Gupta PB, Sgroi DC, et al. Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion. Cell. 2005;121:335
  78. Burger J, Kipps T. CXCR4: A key cross-talk between tumor cells and their microenvironment. Blood. 2006;107:1761
  79. Ceradini DJ, Kulkarni AR, Callaghan MJ, et al. Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1. Nat Med. 2004;10:858
  80. Chiang A, Massague J. Molecular basis of metastasis. N Engl J Med. 2008;359:2814
  81. Hynes R. Metastatic potential: Generic predisposition of the primary tumor or rare, metastatic variants—or both?. Cell. 2003;113:821
  82. Hansson M, Lundgren A, Elgbratt K, et al. Dendritic cells express CCR7 and migrate in response to CCL19 (MIP-3b) after exposure to Helicobacter pylori. Microb Infect. 2006;8:841

PII: S0022-4804(10)00108-3

doi: 10.1016/j.jss.2010.02.012

Journal of Surgical Research
Volume 166, Issue 2 , Pages 255-264 , April 2011

Article Tools

* Image Usage & Resolution